medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2021-41-20-26medalphabet-2417Research ArticleОБОЗРЕНИЕREVIEW«Долгий ковид» (постковидный синдром): механизм возникновения, диагностика и реабилитация‘Long Covid’ (post-covid syndrome): Mechanism of occurrence, diagnosis and rehabilitationЧойЕ. Д.ChoiE. G.

Чой Ен Джун, д.м.н., врач высшей категории, главный врач

Москва

Choi Yong Joon, DM Sci (habil.), physician of superior expert category, chief physician of the Centre

Moscow

info@drchoi.ruЦентр европейской и восточной медицины (ООО «Доктор Чой»)РоссияCentre of European and Oriental Medicine (‘Dr. Choi’ Co.)Russian Federation202109012022041Обозрение (1)2026Copyright © Чой Е.Д., 20222022Чой Е.Д.Choi E.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/2417

Статья посвящена изучению актуальной проблемы современного человечества–борьбе с пандемией, вызванной новой коронавирусной инфекцией, а именно изучению механизма развития «долгого ковида» (постковидного синдрома), новому клинико-лабораторному методу его диагностики, вопросам лекарственной и немедикаментозной реабилитации пациентов, перенесших COVID‑19. В работе описывается этиопатогенез постковидного синдрома (ПС), отличительными особенностями которого является поражение сердечно-сосудистой, дыхательной, нервной, пищеварительной, иммунной систем организма, ЛОР-органов и опорно-двигательного аппарата. Для диагностики постковидного синдрома впервые в РФ апробирован монохромный анализатор наночастиц (МАН), позволяющий определять патофизиологические сдвиги в системе гомеостаза. Установлено, что метод МАН имеет высокую диагностическую чувствительность (78%), а сдвиги в системе гомеостаза при постковидном синдроме являются статистически значимыми (р < 0,001). Принципиально важным моментом данного исследования является то, что разработан алгоритм неинвазивной диагностики ПС по слюне (ротоглоточным смывам), основанный на обнаружении высокого вклада в рассеяние лазерного излучения в среднечастотном диапазоне спектра на наночастицах размером от 119 до 121 нм. Также особое внимание в статье уделяется лекарственным и немедикаментозным методам лечения пациентов с «долгим ковидом», испытывающих на себе последствия перенесенной новой коронавирусной инфекции. Установлено, что наилучший эффект оказывает комплексное лечение, сочетающее методы традиционной европейской школы (медикаментозная терапия с применением сердечно-сосудистых препаратов, ноотропных средств, хондропротекторов, витаминов и минеральных комплексов, гормонов, гепатопротекторов, биостимуляторов, седативных и противовоспалительных средств и других препаратов) и немедикаментозные методы восстановительного лечения, практикуемые восточной медициной (иглорефлексотерапия, гирудотерапия, массаж, остеопатия и т.д.).

The article is devoted to the study of an urgent problem of modern humanity – the fight against a pandemic caused by a new coronavirus infection, namely: the study of the mechanism of development of ‘long Covid’ (post-covid syndrome), a new clinical and laboratory method of its diagnosis, issues of drug and non-drug rehabilitation of patients who have suffered COVID‑19. The paper describes the etiopathogenesis of post-covid syndrome (PS), the distinctive features of which are the defeat of the cardiovascular, respiratory, nervous, digestive, immune systems of the body, ENT organs and musculoskeletal system. For the diagnosis of post-covid syndrome, a monochrome nanoparticle analyzer (MAN) has been tested for the first time in the Russian Federation, which allows determining pathophysiological shifts in the homeostasis system. It was found that the MAN method has a sufficiently high diagnostic sensitivity (78%), and shifts in the homeostasis system in post-covid syndrome are statistically significant (p < 0.001). A fundamentally important point of this study is that an algorithm has been developed for noninvasive diagnosis of PS by saliva (oropharyngeal flushes), based on the detection of a high contribution to the scattering of laser radiation in the mid-frequency range of the spectrum on nanoparticles ranging in size from 119 to 121 nm. The article also pays special attention to medicinal and non-medicinal methods of treatment of patients with ‘long Covid’ experiencing the consequences of a new coronavirus infection. It has been established that the best effect is provided by complex treatment combining methods of the traditional European school (drug therapy with the use of cardiovascular drugs, nootropic agents, chondroprotectors, vitamins and mineral complexes, hormones, hepatoprotectors, biostimulants, sedatives and anti-inflammatory drugs and other drugs) and non-drug methods of restorative treatment practiced by Oriental medicine (acupuncture, hirudotherapy, massage, osteopathy, etc.).

COVID‑19«долгий ковид»постковидный синдроммонохромный анализ наночастицдиагностикалечениереабилитацияCOVID‑19‘long Covid’post-covid syndromemonochrome analysis of nanoparticlesdiagnosistreatmentrehabilitationReferencesПокровский ВИ, Киселев ОИ, Назаров ПГ. SARS: тяжелый острый респираторный синдром. Новый вирус, новая болезнь. Цитокины и воспаление. 2003; 2 (2): 42–51.Pokrovsky VI, Kiselev OI, Nazarov PG. SARS: severe acute respiratory syndrome. New virus, new disease. Tsitokiny i vospalenie. Cytokines and Infl ammation. 2003; 2 (2): 42–51 (In Russ.)Буланов А.Ю., Ройтман Е. В. Новая коронавирусная инфекция, система гемостаза и проблемы дозирования гепаринов: это важно сказать сейчас. Тромбоз, гемостаз и реология. 2020; 2: 11–18. DOI:10.2555/THR.2020.2.0913.Bulanov A. Yu., Roitman E.V. Novaya koronavirusnaya infekciya, sistema gemostaza i problemy dozirovaniya geparinov: eto vazhno skazat’ sejchas. Tromboz, gemostaz i reologiya. 2020; 2: 11–18. (In Russ) DOI:10.2555/THR.2020.2.0913.Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)». Министерство здравоохранения Российской Федерации, 2020 г. Версия 7. 166 с. Режим доступа: http://mpmo.ru/content/2020/06/Metodicheskie–recomendatsiiminzdrava-RF-versiya-7.pdf.Vremennye metodicheskie rekomendacii “Profilaktika, diagnostika i lechenie novoj koronavirusnoj infekcii (COVID‑19)”. 7 versiya. Available from: http://mpmo.ru/content/2020/06/Metodicheskie-recomendatsii-minzdra-va-RF-versiya-7.pdf. (In Russ)Paules CI, Marston HD, Fauci AS. Coronavirus infections – more than just the common cold. JAMA. 2020; 323 (8): 707–8. https://doi.org/10.1001/jama.2020.0757Paules CI, Marston HD, Fauci AS. Coronavirus infections – more than just the common cold. JAMA. 2020; 323 (8): 707–8. https://doi.org/10.1001/jama.2020.0757Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, et al. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J Med Virol. 2020. [Epub ahead of print] https://doi.org/10.1002/jmv.25709Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, et al. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J Med Virol. 2020. [Epub ahead of print] https://doi.org/10.1002/jmv.25709Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl. J Med. 2020. [Epub ahead of print] https://doi.org/10.1056/NEJMoa2002032Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl. J Med. 2020. [Epub ahead of print] https://doi.org/10.1056/NEJMoa2002032The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) – China, 2020. China CDC Weekly. 2020; 2 (8): 113–22.The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) – China, 2020. China CDC Weekly. 2020; 2 (8): 113–22.Rosio H, Varpula M, Hagve TA, Karlsson S, Ruokonen E, Pettilä V, et al. Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med. 2011; 37 (1): 77–85. https://doi.org/10.1007/s00134–010–2051-xRosio H, Varpula M, Hagve TA, Karlsson S, Ruokonen E, Pettilä V, et al. Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med. 2011; 37 (1): 77–85. https://doi.org/10.1007/s00134–010–2051-xKlompas M, Branson R, Eichenwald EC, Greene LR, Howell MD, Lee G, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014; 35 (8): 915–36. https://doi.org/10.1086/677144Klompas M, Branson R, Eichenwald EC, Greene LR, Howell MD, Lee G, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014; 35 (8): 915–36. https://doi.org/10.1086/677144Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006; 3 (9): e343. https://doi.org/10.1371/journal.pmed.0030343Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006; 3 (9): e343. https://doi.org/10.1371/journal.pmed.0030343WHO. Coronavirus disease (COVID‑19) pandemic. Geneva: WHO; 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.WHO. Coronavirus disease (COVID‑19) pandemic. Geneva: WHO; 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.World Health Organization. Infection prevention and control during health care when COVID-19 is suspected. Available from: https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125.World Health Organization. Infection prevention and control during health care when COVID-19 is suspected. Available from: https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125.The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) – China, 2020. China CDC Weekly. 2020, 2 (8): 113–122. Available from: http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4–41e9–9a9b-fea8db1a8f51.The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) – China, 2020. China CDC Weekly. 2020, 2 (8): 113–122. Available from: http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4–41e9–9a9b-fea8db1a8f51.Атлас по медицинской микробиологии, вирусологии и иммунологии. Учебное пособие для студентов медицинских вузов/ Под ред. А.А. Воробьева, А.С. Быкова. М.: Медицинское информационное агентство, 2003. 121 с.Атлас по медицинской микробиологии, вирусологии и иммунологии. Учебное пособие для студентов медицинских вузов/ Под ред. А.А. Воробьева, А.С. Быкова. М.: Медицинское информационное агентство, 2003. 121 с.Atlas po meditsinskoy mikrobiologii, virusologii i immunologii. Uchebnoye posobiye dlya studentov meditsinskikh vuzov. Ed by A.A. Vorob’yev, A. S. Bykov. Moscow: Meditsinskoye informatsionnoye agentstvo; 2003. 121 p. (In Russ.)Atlas po meditsinskoy mikrobiologii, virusologii i immunologii. Uchebnoye posobiye dlya studentov meditsinskikh vuzov. Ed by A.A. Vorob’yev, A. S. Bykov. Moscow: Meditsinskoye informatsionnoye agentstvo; 2003. 121 p. (In Russ.)Woo P, Huang Y, Lau S, Yuen KY. Coronavirus genomics and bioinformatics analysis. Viruses. 2010; 2 (8): 1804–1820. DOI:10.3390/v2081803.Woo P, Huang Y, Lau S, Yuen KY. Coronavirus genomics and bioinformatics analysis. Viruses. 2010; 2 (8): 1804–1820. DOI:10.3390/v2081803.Gaunt ER, Hardie A, Claas EC, et al. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex realtime PCR method. J Clin Microbiol. 2010; 48 (8): 29407294. DOI:10.1128/JCM.00636–10.Gaunt ER, Hardie A, Claas EC, et al. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex realtime PCR method. J Clin Microbiol. 2010; 48 (8): 29407294. DOI:10.1128/JCM.00636–10.Gaunt ER, Hardie A, Claas EC, et al. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex realtime PCR method. J Clin Microbiol. 2010; 48 (8): 2940–2947. DOI:10.1128/JCM.00636–10.Gaunt ER, Hardie A, Claas EC, et al. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex realtime PCR method. J Clin Microbiol. 2010; 48 (8): 2940–2947. DOI:10.1128/JCM.00636–10.Cheng VC, Lau SK, Woo PC, Yuen KY. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin. Microbiol. Rev. 2007; 20 (4): 660–694. DOI:10.1128/CMR.00023–07.Cheng VC, Lau SK, Woo PC, Yuen KY. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin. Microbiol. Rev. 2007; 20 (4): 660–694. DOI:10.1128/CMR.00023–07.Wolfel R, Corman MV, Guggemos W, et al. Virological assessment of hospitalized cases of coronavirus disease 2019. Nature. 2020. DOI:10.1038/s41586–020–2196-x.Wolfel R, Corman MV, Guggemos W, et al. Virological assessment of hospitalized cases of coronavirus disease 2019. Nature. 2020. DOI:10.1038/s41586–020–2196-x.Alserehi H., Wali G., Alshukairi A., Alraddadi B. Impact of Middle East respiratory syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome. BMC Infect Dis. 2016; 16: 105–108.Alserehi H., Wali G., Alshukairi A., Alraddadi B. Impact of Middle East respiratory syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome. BMC Infect Dis. 2016; 16: 105–108.Bassetti M. The Novel Chinese Coronavirus (2019-nCoV) Infections: challenges for fighting the storm. https://doi.org/10.1111/eci.13209 URL: https://onlinelibrary.wiley.com/doi/abs/10.1111/eci.13209Bassetti M. The Novel Chinese Coronavirus (2019-nCoV) Infections: challenges for fighting the storm. https://doi.org/10.1111/eci.13209 URL: https://onlinelibrary.wiley.com/doi/abs/10.1111/eci.13209Cao B., Wang Y., Wen D. et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19. New England Jurnal Medicine.2020; DOI:10.1056/NEJMoa2001282.Cao B., Wang Y., Wen D. et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19. New England Jurnal Medicine.2020; DOI:10.1056/NEJMoa2001282.

The authors declare that there are no conflicts of interest present.